Arrowhead Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ARWR Nasdaq 2834 http://arrowheadpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock - Dec 4th, 2019 11:00 am
Edited Transcript of ARWR earnings conference call or presentation 25-Nov-19 9:30pm GMT - Dec 3rd, 2019 9:58 pm
Where to Buy Booming Biotech ETFs - Dec 3rd, 2019 2:26 pm
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? - Dec 3rd, 2019 11:55 am
This Highly Rated Biotech Company Just Tumbled 13% On A Public Offering - Dec 2nd, 2019 9:48 pm
Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock - Dec 2nd, 2019 9:05 pm
7 Exciting Biotech Stocks to Buy Now - Dec 2nd, 2019 7:57 pm
This Biotech With 488% Growth In 2019 Just Gained A Price-Target Boost - Nov 29th, 2019 6:23 pm
Biotech Arrowhead Stock’s Surge Will Continue, Analyst Says - Nov 29th, 2019 2:52 pm
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)? - Nov 28th, 2019 1:07 pm
The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen - Nov 27th, 2019 12:26 pm
Arrowhead Pharmaceuticals, Inc. Just Missed Earnings And Its EPS Looked Sad - But Analysts Have Updated Their Models - Nov 27th, 2019 9:55 am
Arrowhead Pharmaceuticals to Participate in Upcoming December 2019 Conferences - Nov 26th, 2019 9:00 pm
Arrowhead Pharmaceuticals Reports Fiscal Year 2019 Results - Nov 25th, 2019 9:00 pm
Novartis’s Deal for Medicines Company Is Good News for 2 More Stocks - Nov 25th, 2019 3:27 pm
Arrowhead Presents New Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at AHA Scientific Sessions 2019 - Nov 18th, 2019 2:32 pm
Arrowhead Pharmaceuticals Announces Planned Management Transition - Nov 15th, 2019 12:30 pm
Arrowhead Shares Are Still Alerting Big Buy Signals - Nov 13th, 2019 7:12 pm